Tag: revascularisation
EuroPCR 2026: Routine PCI provides “limited advantage” compared with medical therapy following TAVI
Routine percutaneous coronary intervention (PCI) may provide only “limited advantage” compared w...
CX 2024: Paclitaxel device restrictions “did cause harm”
“Unfortunately, we are doing worse for our patients today,” were the sobering words of Eric Sece...
Black patients nearly 50% less likely to receive revascularisation for PAD
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) ...
Abiomed initiates online education platform for PCI
Abiomed has launched a virtual physician education programme, CAMP PCI (Coronary artery and myoc...
AHA 2019: ISCHEMIA shows no benefit for revascularisation in patients with stable ischaemic heart disease
The largest trial to date to compare revascularisation with a conservative strategy in patients ...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based ther...
ACC releases new appropriate use criteria for coronary revascularisation
The American College of Cardiology (ACC), along with several partnering organisations, has released ...
